ATE263160T1 - Tocotrienolchinon- zyklisierungsprodukte mit antihypercholesterin wirkung - Google Patents

Tocotrienolchinon- zyklisierungsprodukte mit antihypercholesterin wirkung

Info

Publication number
ATE263160T1
ATE263160T1 AT01969391T AT01969391T ATE263160T1 AT E263160 T1 ATE263160 T1 AT E263160T1 AT 01969391 T AT01969391 T AT 01969391T AT 01969391 T AT01969391 T AT 01969391T AT E263160 T1 ATE263160 T1 AT E263160T1
Authority
AT
Austria
Prior art keywords
tocotrienolquinone
antihypercholesterol
effect
sup
cycling products
Prior art date
Application number
AT01969391T
Other languages
English (en)
Inventor
Kai-Uwe Baldenius
Hartwig Schroeder
Klaus Kraemer
Karin Schein
Rainer Stuermer
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Application granted granted Critical
Publication of ATE263160T1 publication Critical patent/ATE263160T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/94Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom spiro-condensed with carbocyclic rings or ring systems, e.g. griseofulvins
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Food Science & Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Polymers & Plastics (AREA)
  • Cardiology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Furan Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
AT01969391T 2000-07-14 2001-07-13 Tocotrienolchinon- zyklisierungsprodukte mit antihypercholesterin wirkung ATE263160T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10034233A DE10034233A1 (de) 2000-07-14 2000-07-14 Tocotrienolchinon-Cyclisierungsprodukte
PCT/EP2001/008163 WO2002006261A1 (de) 2000-07-14 2001-07-13 Tocotrienolchinon-zyklisierungsprodukte mit antihypercholesterin wirkung

Publications (1)

Publication Number Publication Date
ATE263160T1 true ATE263160T1 (de) 2004-04-15

Family

ID=7648895

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01969391T ATE263160T1 (de) 2000-07-14 2001-07-13 Tocotrienolchinon- zyklisierungsprodukte mit antihypercholesterin wirkung

Country Status (10)

Country Link
US (1) US6977270B2 (de)
EP (1) EP1301501B1 (de)
JP (1) JP2004504313A (de)
CN (1) CN1441793A (de)
AT (1) ATE263160T1 (de)
AU (1) AU2001289659A1 (de)
DE (2) DE10034233A1 (de)
DK (1) DK1301501T3 (de)
ES (1) ES2218448T3 (de)
WO (1) WO2002006261A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120046237A1 (en) * 1998-04-08 2012-02-23 Theoharides Theoharis C Compositions for protection against superficial vasodilator flush syndrome, and methods of use
ES2714900T3 (es) 2005-06-01 2019-05-30 Bioelectron Tech Corp Productos terapéuticos redox activos para el tratamiento de enfermedades mitocondriales y otras afecciones y modulación de biomarcadores energéticos
WO2007035496A1 (en) * 2005-09-15 2007-03-29 Edison Pharmaceuticals, Inc. Tail variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers
WO2007100652A2 (en) 2006-02-22 2007-09-07 Edison Pharmaceuticals, Inc. Side chain variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers
JP2012502064A (ja) 2008-09-10 2012-01-26 エジソン ファーマシューティカルズ, インコーポレイテッド 酸化還元活性治療剤を用いての広汎性発達障害の処置
MY157119A (en) * 2008-10-28 2016-05-13 Edison Pharmaceuticals Inc Process for the production of alpha-tocotrienol and derivatives
HUE037574T2 (hu) 2009-04-28 2018-09-28 Bioelectron Tech Corp Leber-féle örökletes optikus neuropátia és domináns optikus atrofia kezelése tokotrienol kinonokkal
CA2772294C (en) * 2009-08-26 2018-08-21 Guy M. Miller Methods for the prevention and treatment of cerebral ischemia
JP2014520894A (ja) 2011-07-19 2014-08-25 エジソン ファーマシューティカルズ, インコーポレイテッド 非アルファトコトリエノールの存在下でのアルファトコトリエノールの選択的酸化のための方法
EP2858639B1 (de) 2012-06-08 2018-09-12 The Ohio State University Behandlung von narbengewebe mit tocotrienol
JP7117241B2 (ja) 2015-12-16 2022-08-12 ピーティーシー セラピューティクス, インコーポレイテッド 混合されたトコール組成物からアルファ-トコトリエノールを富化するための改良された方法
EP3389646A1 (de) 2015-12-17 2018-10-24 BioElectron Technology Corporation Flouralkyl, flouralkoxy, phenoxy, heteroaryloxy, alkoxy und amin-1,4-benzochinon-derivate zur behandlung von oxidativen stresserkrankungen

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5217992A (en) * 1989-10-04 1993-06-08 Bristol-Myers Squibb Company Tocotrienols in the treatment of hypercholesterolemia, hyperlipidemia and thromboembolic disorders
KR910007523A (ko) 1989-10-04 1991-05-30 브리스톨-마이어즈 스퀴브 컴페니 과콜레스테린혈증, 과지방혈증 및 혈전색전증 질병 치료용 토코트리엔올
CA2050514A1 (en) 1990-09-14 1992-03-15 Bradley C. Pearce Acyclic tocotrienol analogs in the treatment of hypercholesterolemia and hyperlipidemia
CA2096496A1 (en) 1992-05-29 1993-11-30 Bradley C. Pearce Acyclic tocotrienol analogs in the treatment of hypercholesterolemia and hyperlipidemia
US5318993A (en) * 1993-04-16 1994-06-07 Bristol-Myers Squibb Company Antihyperlipidemic benzoquinones
EP0669132A1 (de) 1994-02-23 1995-08-30 van der Kraaij, Antonius Marinus Maria Kombinationspräparat von Vitamine E und Acetylsalicylate zur Behandlung und Prophylaxis des Atherosclerosis
JP3926888B2 (ja) 1997-05-27 2007-06-06 株式会社カネカ コレステロール低下剤

Also Published As

Publication number Publication date
EP1301501B1 (de) 2004-03-31
JP2004504313A (ja) 2004-02-12
DK1301501T3 (da) 2004-07-19
DE50101861D1 (de) 2004-05-06
EP1301501A1 (de) 2003-04-16
DE10034233A1 (de) 2002-01-24
US20040116715A1 (en) 2004-06-17
WO2002006261A1 (de) 2002-01-24
ES2218448T3 (es) 2004-11-16
AU2001289659A1 (en) 2002-01-30
CN1441793A (zh) 2003-09-10
US6977270B2 (en) 2005-12-20

Similar Documents

Publication Publication Date Title
PT1109812E (pt) Pirrolobenzodiazepinas
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
DE69803907D1 (de) Fungizide 2-Methoxybenzophenone
DE60012188D1 (de) Fungizide
SE9900100D0 (sv) New compounds
ECSP034896A (es) Derivados aromaticos de acidos dicarboxilicos
DK0931788T3 (da) Metalloproteasehæmmere
PT1453512E (pt) Derivados de acetileno tendo actividade antagonistica do mglur 5
SE0004245D0 (sv) Novel compounds and their use
DE60229736D1 (de) Spiroinden- und spiroindan-verbindungen
DK1385515T3 (da) Spiropyrazole forbindelser
DK1100789T3 (da) Substituerede benzoylcyclohexandioner
ATE263160T1 (de) Tocotrienolchinon- zyklisierungsprodukte mit antihypercholesterin wirkung
SE0100326D0 (sv) New compounds
TR200201128T2 (tr) PDE4 inhibitörleri olarak tetrahidrotiyopiranfitalazinon türevleri.
CA2412596A1 (en) Cyclic gmp-specific phosphodiesterase inhibitors
WO2002011737A3 (en) Anti-inflammatory medicament
SE9903290D0 (sv) Novel compounds
DK1204659T3 (da) Serotonerge benzofuraner
DE60121048D1 (de) PYRAZINOi1'2':1,6öPYRIDOi3,4-BöINDOLDERIVATE
ATE182594T1 (de) Thiazolotriazol- und thiazolodiazolderivate mit fungizider aktivität
DK0713485T3 (da) Thiocarbamoylforbindelser som mikrobicider
SE9902268D0 (sv) Pharmaceutically active compounds
IT1262952B (it) Tetraalchilpiperidine, loro preparazione e loro impiego come stabilizzanti alla luce. (caso 153-5502)
NO20025410L (no) Anvendelse av stannylener og germylener som polymerisasjonskatalysatorer for heterocykler

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee